BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 3, 2015
View Archived Issues
Purdue Pharma divulges new opioid receptor agonists
Read More
FDA advisory committee completes new review of Fabre-Kramer's gepirone ER
Read More
S1P2 receptor antagonist shows promise for fibrosis
Read More
Probing the role of FKBP5 in the epigenetic effects of paroxetine
Read More
Phase III trial AFFINITY of custirsen in mCRPC to continue following futility analysis
Read More
FAK inhibitor GSK-2256098 reaches glioblastoma tumor tissue in patients
Read More
Ignyta's entrectinib first drug selected for the SPECTA biomarker screening initiative
Read More
Bristol-Myers Squibb discloses HCV NS5B inhibitors
Read More
Roche and Genentech present JAK inhibitors
Read More
Newron begins U.S. phase II trial of NW-3509 in patients with schizophrenia
Read More
Kamada provides update on alpha1-antitrypsin development in type 1 diabetes
Read More
Shionogi's Mulpleta launched in Japan
Read More
Reinnervate's Alvetex scaffold used in 3D models of skin and neuronal tissue
Read More
Atea plans clinical development of new hepatitis C virus polymerase inhibitors
Read More
Anti-survivin vaccine induces immune response in phase II trial in DLBCL
Read More
GSK launches Nucala in U.S.
Read More
Assurex Health expands utility of GeneSight Psychotropic test
Read More
Phase I trial results of T1D immunotherapy with autologous polyclonal Tregs
Read More
ORIC Pharmaceuticals announces Series B financing
Read More
Apricus confirms strategy for fispemifene, following FDA guidance on enclomiphene
Read More
Pradigastat reduces liver fat in patients with nonalcoholic fatty liver disease
Read More
HiberGene's meningococcal disease diagnostic receives CE Mark
Read More
TxCell reacquires full rights to Ovasave
Read More
Celleron reports results from first clinical study of HDAC inhibitor CXD-101
Read More
FDA places Zafgen's phase III trial of beloranib in Prader-Willi syndrome on full clinical hold
Read More